Journal of clinical microbiology

[1] Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Vaginitis Assays: Results from a Prospective Multicenter Clinical Study.

[2] sexually transmitted infections associated with vulvovaginal symptoms in adolescents denying sexual activity infecciones de transmisión sexual asociadas a síntomas vulvovaginales en adolescentes que niegan vida sexual activa

[3] vaginitis caused by conditionally pathogenic microflora: international and home protocols analysis

[4] do the interactions between coital frequency, cervical length, and urogenital infection affect obstetric outcomes?

[5] diagnosis of bacterial vaginosis by a new multiplex peptide nucleic acid fluorescence in situ hybridization method

[6] Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: clinical outcomes, impacts of sex and menses

[7] Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: clinical outcomes, impacts of sex and menses

[8] Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: clinical outcomes, impacts of sex and menses

[9] Asymptomatic Bacterial Vaginosis in Pregnancy and Missed Opportunities for Treatment: A Cross-Sectional Observational Study

[10] Acceptability of and treatment preferences for recurrent bacterial vaginosis-Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial.

[11] Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Vaginitis Assays: Results from a Prospective Multicenter Clinical Study.

[12] Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial Vaginosis

[13] Indications for Therapy and Treatment Recommendations for Bacterial Vaginosis in Nonpregnant and Pregnant Women: A Synthesis of Data

[14] performance of bvblue rapid test in detecting bacterial vaginosis among women in mysore, india

[15] bacterial vaginosis and trichomoniasis: epidemiology and management of recurrent disease

[16] the influence of bacterial vaginosis on gestational week of the completion of delivery and biochemical markers of inflammation in the serum

[17] comparison of the effect of vaginal zataria multiflora cream and oral metronidazole pill on results of treatments for vaginal infections including trichomoniasis and bacterial vaginosis in women of reproductive age

[18] efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis

[19] the efficacy and safety of a single dose of clindesse™ vaginal cream versus a seven-dose regimen of cleocin® vaginal cream in patients with bacterial vaginosis

[20] diagnosis of bacterial vaginosis by a new multiplex peptide nucleic acid fluorescence in situ hybridization method

[21] evaluation of demografic and clinical characters of patients whit bacterial vaginosis in ahwaz amir almoomenin hospital.

[22] detection of fastidious vaginal bacteria in women with hiv infection and bacterial vaginosis

[23] gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient

[24] effects of pregnancy and bacterial vaginosis on proinflammatory cytokine and secretory leukocyte protease inhibitor concentrations in vaginal secretions

[25] maternal vitamin d, folate, and polyunsaturated fatty acid status and bacterial vaginosis during pregnancy

[26] a multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection

[27] the effect of calendula officinalis versus metronidazole on bacterial vaginosis in women: a double-blind randomized controlled trial

[28] Interleukin-36γ Is Elevated in Cervicovaginal Epithelial Cells in Women With Bacterial Vaginosis and In Vitro After Infection With Microbes Associated With Bacterial Vaginosis